Service IPEB – Dated 20030923 |
VA - (9 Years Post-Separation) | ||||||
Condition |
Code | Rating | Condition | Code | Rating | Exam | |
Asthma |
6602 | 10% | Asthma | 6602 | 30% | 20121226 | |
Pulmonary Histoplasmosis |
CAT III | No VA Entry | |||||
No Additional MEB/PEB Entries |
Other x 2 | 20121226 | |||||
Combined: 10% |
Combined: 30% |
Pulmonary Exam |
PFT ~13 Mo. Pre-Sep | PFT ~ 9 Mo. Pre-Sep | |
FEV1 (% Predicted) |
77 | 73 | |
FEV1/FVC |
8 6 % | 83% | |
Meds |
Daily triamcinolone & albuterol inhalers; montelukast | Daily fluticasone, salmeterol, prn albuterol; montelukast | |
§
4.97
Rating |
10% | 10% |
UNFITTING CONDITION |
VASRD CODE | RATING | |
Asthma |
6602 | 10% | |
COMBINED |
10% |
AF | PDBR | CY2013 | PD-2013-02765
The requested sleep apnea, anxiety, hypertension and rhinitis conditions were not identified by the PEB, and therefore not within the DoDI 6040.44 defined purview of the Board.Any conditions or contention not requested in this application, or otherwise outside the Board’s defined scope of review, remain eligible for future consideration by the Board for Correction of Military Records. Asthma Condition . The PEB TDRL exit rating was 10%,with the disability description stating: “not...
AF | PDBR | CY2012 | PD2012-00289
The narrative summary (NARSUM), service treatment records (STR), and prior to separation VA C&P examination all indicate that the CI required and used daily inhalational bronchodilator and oral medications which would support a 30% rating IAW VASRD code 6602 (“daily inhalational or oral bronchodilator therapy or inhalational anti-inflammatory medication”) and VASRD §4.97. RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge...
AF | PDBR | CY2013 | PD-2013-02236
In December 2004 theMEB found the asthma condition had stabilized sufficiently and the PEB adjudicated “exertion asthma” unfitting, rated at 10% disability and the CI was removed from the TDRL on 30 December 2004. The Board deliberated if the TDRL NARSUM current medications’listing oral Singulair was supported by the record and if it met the VASRD 6602 30% rating criteria for daily oral bronchodilator therapy.The Board discussed the evidence of record concerning Singulair use.Singulair was...
AF | PDBR | CY2012 | PD2012 00466
Asthma . The CI continued to be symptomatic despite his maximal medical regimen.At the MEB exam on 30May 2001, approximately 4months prior to separation, the CI reported some improvement in his SOBbut that he still required a pre-exercise rescue inhaler, often needing to halt PT and required additional rescue inhaler use throughout the day. XXXXXXXXXXXXXXXXXX President Physical Disability Board of Review
AF | PDBR | CY2013 | PD-2013-02064
SEPARATION DATE: 20061204 The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the Veterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. Asthma Condition .
AF | PDBR | CY2013 | PD-2013-01954
SEPARATION DATE: 20050331 The Board found the CI met the higher 30% evaluation due to “ inhalational anti-inflammatory medication” (Advair)use at the time of separation as specified under code 6602.After due deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable doubt), the Board recommends a disability rating of 30% for the asthma condition. Under the authority of Title 10, United States Code, section 1554(a), I approve the enclosed recommendation of the...
AF | PDBR | CY2013 | PD-2013-01552
The service treatment record (STR) initially reflected that the CI wasbeing worked-up for a respiratory condition noting the first of many spirometry/pulmonary function tests (PFTs) dated 28 August 2002. The CI was never placed on oral corticosteroids; therefore, Board members deliberated if the CI’s condition supported the 30% criteria level.Clearly, the final pulmonology report noted no use of medication for the previous “several months.”Additionally, the post-separation VA examination...
AF | PDBR | CY2013 | PD-2013-01963
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the VASRD standards to the unfitting medical condition at the time of separation. The Board next considered that at the time of separation, although the CI’s asthma was relatively well controlled,treatment notes in the STR, the MEB and C&P exams consistently documented use of the anti-inflammatory inhaler and oral bronchodilator medications, with...
AF | PDBR | CY2014 | PD 2014 00205
SEPARATION DATE: 20071029 The narrative summary (NARSUM) performed on 13 June 2007 (4 months prior to separation), the CI reported “consistently feels SOB with exertion.” His physical examination (PE) was normal and the corresponding pulmonary function test (PFT)was 96% and 93% predicted for FEV1 and FVC respectively. Additionally, secondary to the inconsistent documentation, members also considered the probative value between the MEB and VA examination and concluded that the MEB...
AF | PDBR | CY2012 | PD2012 01083
He was issued a permanent P3 profile andreferred for a Medical Evaluation Board (MEB).Asthma and mild restrictive pattern were forwarded to the Physical Evaluation Board (PEB) as medically unacceptable IAW AR 40-501.The PEB adjudicated the asthma and mild restrictive pattern as unfitting, rated 10% with application of the Veteran’s Affairs Schedule for Rating Disabilities (VASRD).The CI made no appeals, and was medically separated with a 10% disability rating. a month prior to the PEB,...